PRO-DEX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PRO-DEX, INC. (PDEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 70.00 thousand shares for the 12-month period ending 2013-06-30, per its 10-K filed 2014-09-18.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2014-09-18
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-06-30 was 10.00K shares, a 95.45% decline year-over-year.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-03-31 was 25.00K shares.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2012-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2012-09-30 was 35.00K shares, a 69.57% decline year-over-year.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 70.00K shares, a 83.53% decline from fiscal 2012.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2012 was 425.00K shares, a 142.86% increase from fiscal 2011.
- PRO-DEX, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2011 was 175.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2013-06-30 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-18 | 35.00K shares derived: sum of 2 quarters · filed 2014-09-18 | 35.00K shares derived: sum of 3 quarters · filed 2014-09-18 | 70.00K shares 10-K · filed 2014-09-18 |
| 2013-03-31 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | 25.00K shares derived: sum of 2 quarters · filed 2014-05-12 | 60.00K shares 10-Q · filed 2014-05-12 | 280.00K shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-06 | 35.00K shares 10-Q · filed 2014-02-06 | 255.00K shares derived: sum of 3 quarters · filed 2014-02-06 | 255.00K shares derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-09-30 | 35.00K shares 10-Q · filed 2013-11-13 | 255.00K shares derived: sum of 2 quarters · filed 2013-11-13 | 255.00K shares derived: sum of 3 quarters · filed 2013-11-13 | 345.00K shares derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | 220.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | 220.00K shares derived: sum of 2 quarters · filed 2013-09-27 | 310.00K shares derived: sum of 3 quarters · filed 2013-09-27 | 425.00K shares 10-K · filed 2013-09-27 |
| 2012-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-13 | 90.00K shares derived: sum of 2 quarters · filed 2013-05-13 | 205.00K shares 10-Q · filed 2013-05-13 | |
| 2011-12-31 | 90.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13 | 205.00K shares 10-Q · filed 2013-02-13 | ||
| 2011-09-30 | 115.00K shares 10-Q · filed 2012-11-08 | |||
| 2011-06-30 | 175.00K shares 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |